Lithicron 0520 P-Synchroneous Pulse Gen.
by Medcor, Inc.
510(k) K792609
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK792609 | Date19 Nov 1980 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Lithicron 0520 P-Synchronous Pulse Generator is an implantable pacemaker pulse-generator, designed to deliver timed electrical impulses to regulate heart rhythm in patients with bradycardia or other cardiac conduction disorders. It operates synchronously with the patient’s natural cardiac cycle to ensure coordinated atrial and ventricular contractions, improving cardiac efficiency and reducing symptoms of arrhythmias.
This device is intended for implantation and is classified as a Class III medical device under FDA regulations (870.3610). It is supplied sterile and intended for single-use implantation by qualified healthcare professionals in clinical settings. The Lithicron 0520 adheres to MRI safety guidelines for implantable cardiac devices, and its specifications are documented under the K-number K792609, with a traditional 510(k) clearance from the FDA’s Cardiovascular Advisory Committee.
Other devices from Medcor, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Lithicron 0520 P-Synchronous Pulse Generator, and how does it differ from standard pacemakers?
The Lithicron 0520 is designed to regulate heart rhythm in patients with bradycardia or cardiac conduction disorders by delivering timed electrical impulses *synchronously* with the patient’s natural cardiac cycle. This ensures coordinated atrial and ventricular contractions, improving cardiac efficiency and reducing arrhythmia symptoms. Unlike basic pacemakers, its synchronous functionality distinguishes it by aligning pacing with the patient’s existing heartbeat, enhancing physiological coordination.
Is this device intended for reuse, or is it meant for single-use implantation only?
The Lithicron 0520 is explicitly supplied sterile and intended for *single-use implantation* by qualified healthcare professionals. It is not designed for reuse, aligning with standard practices for implantable cardiac devices to ensure patient safety and sterility.
What regulatory pathway did this device follow to gain market authorization in the U.S., and which committee reviewed it?
The Lithicron 0520 received a traditional 510(k) clearance from the FDA’s Cardiovascular Advisory Committee (CV), demonstrating it is *substantially equivalent* to a predicate device. The review process involved the committee’s evaluation under the product code DXY and device classification 870.3610, confirming its compliance with regulatory standards for implantable pacemaker pulse-generators.
Does this device have any special considerations for MRI compatibility, and how might that affect patient care?
Yes, the Lithicron 0520 adheres to MRI safety guidelines for implantable cardiac devices, meaning it is designed with features to minimize risks during MRI procedures. This allows patients to undergo MRI scans under controlled conditions, though precautions would still apply to avoid interference with the device’s function or potential heating risks.
What are the key specifications or identifiers for this device, particularly for inventory or ordering purposes?
For inventory or ordering, the Lithicron 0520 is identified by its K-number (K792609) and is classified under the FDA’s product code DXY. The device is listed under registration numbers like 2017865 and 3005334138, which may be referenced for compliance or traceability. These identifiers help distinguish it from other pacemaker models in regulatory databases.